Chronic lymphocytic leukemia with IGH :: BCL3 ‐translocation is characterized by a homogeneous and distinct genetic and epigenetic landscape
HemaSphere · 2026-05 · 10 (5)
DOI: 10.1002/hem3.70354 ↗Kurz gefasst
Fachartikel in der Zeitschrift HemaSphere, online erschienen am 29.04.2026. Verfasst von Cosima Drewes und 24 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Ulm University and Ulm University Medical Center Ulm Germany. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Approximately 1% of chronic lymphocytic leukemia (CLL) cases harbor a translocation juxtaposing the immunoglobulin heavy chain ( IGH ) and B‐cell lymphoma 3 ( BCL3 ) loci. Aiming at comprehensive molecular characterization of IGH :: BCL3‐ positive B‐cell neoplasms, we here investigated samples from 84 patients using fluorescence in situ hybridization (FISH), whole‐genome and targeted sequencing, and DNA methylation analyses. Junctional sequences obtained in 27 patients showed breakpoints upstream of BCL3 in all CLL cases. IGH breaks were presumably driven by aberrant class‐switch recombination in 26/27 cases, frequently involving IGHA (12/26). Notably, 95% (78/82) of patients carried an unmutated IGHV with significant CLL stereotype subset #8 enrichment. Trisomy 12 (61%, 51/83) and mutations affecting NOTCH1 (32%, 25/79), BRAF (14%, 11/79), and FBXW7 (14%, 11/79) were frequent aberrations. DNA methylation analysis assigned 77% (51/66) of patients with IGH :: BCL3‐ translocation with at least 60% tumor cell content to the naive B‐cell‐like group but unraveled a distinct and during follow‐up stable signature resembling in part plasma cell‐like epigenetic features. A binary DNA methylation classifier using 20 CpGs could distinguish IGH :: BCL3 ‐translocated CLL samples from other CLL subtypes. In an efficacy cohort of 3832 previously untreated patients from GCLLSG trials, IGH::BCL3 was associated with shorter progression‐free survival (PFS) and overall survival (OS) in 28 patients when treated with chemoimmunotherapy, but not in those receiving venetoclax. Our findings highlight the genetic and epigenetic homogeneity of IGH :: BCL3 ‐translocated CLL samples and their differences from other types of CLL, suggesting IGH :: BCL3 leukemic B‐cell neoplasms to be a biological distinct type within the spectrum of mature lymphatic leukemia/CLL.
Autor:innen und Institutionen
- Institute of Human Genetics, Ulm University and Ulm University Medical Center Ulm Germany.
- Molecular Pathology of Lymphoid Neoplasms Group Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.
- Hematopathology Section, Pathology Department Hospital Clínic de Barcelona Barcelona Spain.
- Departament de Fonaments Clínics Universitat de Barcelona Barcelona Spain.
- Department of Computer Science and Artificial Intelligence University of Granada, Andalusian Research Institute in Data Science and Computational Intelligence Granada Spain.
- Instituto de Investigación Sanitaria ibs, GRANADA, Hospitales Universitarios de Granada-Universidad de Granada Granada Spain.
ORCID-Profile: Cosima Drewes, Juan Emilio Martinez-Manjón, Barbara Eichhorst
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Drewes, C., López, C., Martinez-Manjón, J. E., Okeke, N., Jebaraj, B., Bens, S., Brändl, B., Dyer, M. J. S., Eichhorst, B., Fischer, A., Fischer, K., Robrecht, S., Hallek, M., Glaser, S., Hillebrecht, S., Jayne, S., Kretzmer, H., Mottok, A., Müller, F. J., …, & Siebert, R. (2026). Chronic lymphocytic leukemia with IGH :: BCL3 ‐translocation is characterized by a homogeneous and distinct genetic and epigenetic landscape. HemaSphere, 10(5). https://doi.org/10.1002/hem3.70354
Vancouver
Drewes C, López C, Martinez-Manjón JE, Okeke N, Jebaraj B, Bens S, et al. Chronic lymphocytic leukemia with IGH :: BCL3 ‐translocation is characterized by a homogeneous and distinct genetic and epigenetic landscape. HemaSphere. 2026;10(5). doi:10.1002/hem3.70354
BibTeX
@article{Drewes2026,
author = {Drewes, Cosima and López, Cristina and Martinez-Manjón, Juan Emilio and Okeke, Nnamdi and Jebaraj, Billy and Bens, Susanne and Brändl, Björn and Dyer, Martin J S and Eichhorst, Barbara and Fischer, Anja and Fischer, Kirsten and Robrecht, Sandra and Hallek, Michael and Glaser, Selina and Hillebrecht, Sina and Jayne, Sandrine and Kretzmer, Helene and Mottok, Anja and Müller, Franz-Josef and Schneider, Christof and Ammerpohl, Ole and Del Val, Coral and Stilgenbauer, Stephan and Tausch, Eugen and Siebert, Reiner},
title = {Chronic lymphocytic leukemia with IGH :: BCL3 ‐translocation is characterized by a homogeneous and distinct genetic and epigenetic landscape},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {5},
doi = {10.1002/hem3.70354}
}
EUVIMED